Osteotech Tissue Recall Traced To Equipment Malfunction In Electrical Storm
This article was originally published in The Gray Sheet
Executive Summary
Osteotech is testing the rework procedure it developed to resterilize recalled and quarantined donor tissue and hopes to have the procedure validated and in place by year-end
You may also be interested in...
CDRH Examining CryoLife Heart Valve Risks Following Tissue Recall
CDRH is reviewing potential risks associated with CryoValve heart valves in the wake of an Aug. 14 recall order for CryoLife human tissue products
FDA Tissue Registration Rule Clarifies Classification Of Combination Devices
Manufacturers of combination devices incorporating human cells or tissues will have until Jan. 19, 2003 to register with FDA, according to a final rule released by the agency Jan. 18.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.